SOPHIRIS BIO
Sophiris Bio Inc. (NASDAQ: SPHS) is a biopharmaceutical company developing a clinical-stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH or enlarged prostate), which it believes is an unsatisfied patient population with significant market potential. Sophiris is currently developing PRX302 for the treatment of BPH symptoms which is designed to be as efficacious as pharmaceuticals, less invasive than the surgical interventions, and without the sexual side effects seen with existing treatments. PRX302 is currently in Phase 3 clinical development with a blinded interim analysis expected in the second half of 2014 followed by a complete data analysis in the second half of 2015. For more information, please visit www.sophiris.com.
SOPHIRIS BIO
Industry:
Biopharma Biotechnology Clinical Trials
Founded:
2002-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.sophiris.com
Total Employee:
1+
Status:
Closed
Contact:
858.777.1760
Email Addresses:
[email protected]
Total Funding:
47.23 M USD
Technology used in webpage:
Font Awesome Apache IPv6 Facebook Sharer Microsoft IIS 8 Network Solutions DNS Citrix NetScaler Time Warner Confluence Networks
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Sophiris Bio
Aspire Capital Partners LLC
Aspire Capital Partners LLC investment in Post-IPO Equity - Sophiris Bio
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Sophiris Bio
Warburg Pincus
Warburg Pincus investment in Venture Round - Sophiris Bio
Official Site Inspections
http://www.sophiris.com
- Host name: 208.91.197.27
- IP address: 208.91.197.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sophiris Bio"
Sophie is… | on a journey of (re)discovery in a brave …
We are living in a world where the truth no longer holds any sway in the pursuit and consolidation of power. Nowhere is this more obvious than in the sordid beginnings of Donald Trump’s America: in the run up to the election the lies …See details»
Sophiris Company Profile - Office Locations, Competitors ... - Craft
See insights on Sophiris including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Sophiris Bio - Crunchbase Company Profile & Funding
Sophiris Bio is a biotech company that develops a treatment for the symptoms of benign prostatic hyperplasia. Their product includes topsalysin for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia and for the …See details»
Sophiris Bio Inc. - AnnualReports.com
Sophiris Bio Inc. is a late-stage clinical biopharmaceutical company developing topsalysin (PRX302) for the treatment of patients with urological diseases.See details»
Sophiris Bio To Shut Down Operations | Reuters
May 18, 2020 board formally approved immediate shutdown of operations of coSee details»
Sophiris Bio Corp. Company Profile | La Jolla, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Sophiris Bio Corp. of La Jolla, CA. Get the latest business insights from Dun & Bradstreet.See details»
Sophiris Bio 2025 Company Profile: Valuation, Funding ... - PitchBook
Information on valuation, funding, acquisitions, investors, and executives for Sophiris Bio. Use the PitchBook Platform to explore the full profile.See details»
Sophiris Overview - Salary.com
Discover essential details about Sophiris, including address, contact, and journey of our company's evolution.See details»
Sophiris Bio Inc. - LinkedIn
Sophiris Bio Inc. | 294 followers on LinkedIn. Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseasesSee details»
About - Sophie is...
Up until October 2012, I was a teacher. I'd worked in challenging schools in East London and Plymouth for over ten years, and I loved what I did. It was exhausting, and sometimes …See details»
Sophiris Bio Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sophiris Bio Inc. of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Sophiris Bio - Products, Competitors, Financials, Employees ...
Sophiris Bio is a biopharmaceutical company focused on the development of treatments for urological diseases. Use the CB Insights Platform to explore Sophiris Bio's full profile.See details»
Sophiris Bio To Shut Down Operations - BioSpace
May 18, 2020 SAN DIEGO and VANCOUVER, British Columbia, May 18, 2020 /PRNewswire/ -- Sophiris Bio Inc. (OTCQB: SPHS) (the “Company” or “Sophiris”), today announced that its …See details»
Organizational Culture for Sophiris Bio Inc
Need Help with Sophiris Bio Inc Organizational Culture? Order & download for $12See details»
Sophiris Bio - Contacts, Employees, Board Members ... - Crunchbase
Sophiris Bio is a biopharmaceutical company that develops topsalysin for the treatment of urological diseases.See details»
Sophiris Bio Announces Completion of $4.0 Million Registered …
Aug 30, 2019 SAN DIEGO and VANCOUVER, British Columbia, Aug. 30, 2019 /PRNewswire/ -- Sophiris Bio Inc. (Nasdaq: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical …See details»
Sophiris Bio To Shut Down Operations - Markets Insider
May 18, 2020 SAN DIEGO and VANCOUVER, British Columbia, May 18, 2020 /PRNewswire/ -- Sophiris Bio Inc. (OTCQB: SPHS) (the "Company" or "Sophiris"), today announced that its …See details»
Work with me - Raising Revolutionaries
I am a mother, writer, teacher and activist living in South Devon with my family. My blogging journey began in 2013 with the launch of sophieis.com.It was there I found the voice that had …See details»
Sophiris Bio - Updates, News, Events, Signals & Triggers
May 14, 2018 Sophiris Bio is a biopharmaceutical company that develops topsalysin for the treatment of urological diseases.See details»
Sophiris Bio Closes Underwritten Public Offering - PR Newswire
Aug 26, 2016 SAN DIEGO and VANCOUVER, British Columbia, Aug. 26 2016 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company"), a biopharmaceutical company …See details»